Close
4

Athena Athena

X

Find Diphenhydramine Citrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
105
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

JP

0

Other Listed Suppliers

SERVICES

0

Looking for 88637-37-0 / Diphenhydramine Citrate API manufacturers, exporters & distributors?

Diphenhydramine Citrate manufacturers, exporters & distributors 1

10

PharmaCompass offers a list of Diphenhydramine Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diphenhydramine Citrate manufacturer or Diphenhydramine Citrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diphenhydramine Citrate manufacturer or Diphenhydramine Citrate supplier.

PharmaCompass also assists you with knowing the Diphenhydramine Citrate API Price utilized in the formulation of products. Diphenhydramine Citrate API Price is not always fixed or binding as the Diphenhydramine Citrate Price is obtained through a variety of data sources. The Diphenhydramine Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Diphenhydramine Citrate

Synonyms

88637-37-0, 2-(benzhydryloxy)-n,n-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate, Diphenhydramine citrate [usp], Diphenhydramine (citrate), 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid, 4od433s209

Cas Number

88637-37-0

Unique Ingredient Identifier (UNII)

4OD433S209

About Diphenhydramine Citrate

A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.

Diphenhydramine Citrate Manufacturers

A Diphenhydramine Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diphenhydramine Citrate, including repackagers and relabelers. The FDA regulates Diphenhydramine Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diphenhydramine Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Diphenhydramine Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Diphenhydramine Citrate Suppliers

A Diphenhydramine Citrate supplier is an individual or a company that provides Diphenhydramine Citrate active pharmaceutical ingredient (API) or Diphenhydramine Citrate finished formulations upon request. The Diphenhydramine Citrate suppliers may include Diphenhydramine Citrate API manufacturers, exporters, distributors and traders.

click here to find a list of Diphenhydramine Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Diphenhydramine Citrate USDMF

A Diphenhydramine Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Diphenhydramine Citrate active pharmaceutical ingredient (API) in detail. Different forms of Diphenhydramine Citrate DMFs exist exist since differing nations have different regulations, such as Diphenhydramine Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Diphenhydramine Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Diphenhydramine Citrate USDMF includes data on Diphenhydramine Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diphenhydramine Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Diphenhydramine Citrate suppliers with USDMF on PharmaCompass.

Diphenhydramine Citrate WC

A Diphenhydramine Citrate written confirmation (Diphenhydramine Citrate WC) is an official document issued by a regulatory agency to a Diphenhydramine Citrate manufacturer, verifying that the manufacturing facility of a Diphenhydramine Citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diphenhydramine Citrate APIs or Diphenhydramine Citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Diphenhydramine Citrate WC (written confirmation) as part of the regulatory process.

click here to find a list of Diphenhydramine Citrate suppliers with Written Confirmation (WC) on PharmaCompass.

Diphenhydramine Citrate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diphenhydramine Citrate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Diphenhydramine Citrate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Diphenhydramine Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Diphenhydramine Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diphenhydramine Citrate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Diphenhydramine Citrate suppliers with NDC on PharmaCompass.

Diphenhydramine Citrate GMP

Diphenhydramine Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Diphenhydramine Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diphenhydramine Citrate GMP manufacturer or Diphenhydramine Citrate GMP API supplier for your needs.

Diphenhydramine Citrate CoA

A Diphenhydramine Citrate CoA (Certificate of Analysis) is a formal document that attests to Diphenhydramine Citrate's compliance with Diphenhydramine Citrate specifications and serves as a tool for batch-level quality control.

Diphenhydramine Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Diphenhydramine Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Diphenhydramine Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Diphenhydramine Citrate EP), Diphenhydramine Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diphenhydramine Citrate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY